McKinsey announced that it had bought Elixir. It was a very rare acquisition by McKinsey, which for the first nine decades of its existence had mainly relied on “organic” growth, eschewing mergers and acquisitions, even though it often advised and advocated for them for its clients. McKinsey “never buys anything like this anywhere in the world,” said one former McKinsey partner who worked in the region, speaking about Elixir. “The word was that it was purely for the relationships.”
